Science ❯ Medicine ❯ Clinical Trials
Inhalation Therapy Lenacapavir FDA Studies Oncology
The CHMP’s positive opinion sets the stage for final EU Commission approval to replace high-global-warming-potential propellant with Honeywell’s lower-carbon alternative throughout AstraZeneca’s regional supply
